These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11876083)

  • 1. [Is topiramate effective for weight loss in neuroleptic-induced obesity? 2 case reports].
    Schüler-Springorum M; Hebebrand J; Wehmeier PM; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 Feb; 30(1):51-8. PubMed ID: 11876083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series.
    Kirov G; Tredget J
    BMC Psychiatry; 2005 Apr; 5():19. PubMed ID: 15817130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of available agents used to treat bipolar disorder: focus on weight gain.
    Nemeroff CB
    J Clin Psychiatry; 2003 May; 64(5):532-9. PubMed ID: 12755655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.
    Kotwal R; Guerdjikova A; McElroy SL; Keck PE
    Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial.
    Tramontina S; Zeni CP; Pheula G; Rohde LA
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):129-34. PubMed ID: 17343561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of topiramate in mood stabilization.
    Maidment ID
    Ann Pharmacother; 2002; 36(7-8):1277-81. PubMed ID: 12086564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series.
    Roy Chengappa KN; Levine J; Rathore D; Parepally H; Atzert R
    Eur Psychiatry; 2001 Apr; 16(3):186-90. PubMed ID: 11353598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders.
    Canitano R
    Brain Dev; 2005 Apr; 27(3):228-32. PubMed ID: 15737706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN; Gershon S; Levine J
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate for reversing atypical antipsychotic weight gain.
    Lessig MC; Shapira NA; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1364. PubMed ID: 11765278
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
    Lin YH; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate leukopenia on clozapine.
    Behar D; Schaller JL
    Eur Child Adolesc Psychiatry; 2004 Feb; 13(1):51-2. PubMed ID: 14991432
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype.
    Basu R; Brar JS; Chengappa KN; John V; Parepally H; Gershon S; Schlicht P; Kupfer DJ
    Bipolar Disord; 2004 Aug; 6(4):314-8. PubMed ID: 15225149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine weight gain, plus topiramate weight loss.
    Dursun SM; Devarajan S
    Can J Psychiatry; 2000 Mar; 45(2):198. PubMed ID: 10742883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.